Formulation and Evaluation of Niosomal Gel for Treatment of Acne
Abstract
A skin disease, like acne, is very common and normally happens to everyone at least once in their lifetime. The structure of the stratum corneum is often compared with a brick wall, with corneocytes surrounded by the mortar of the intercellular lipid lamellae. Acne vulgaris is a chronic inflammatory dermatosis which is notable for open and/or closed comedones (blackheads and whiteheads), and inflammatory lesions including papules, pustules, or nodules. It is a disorder of sebaceous follicles which are special pilosebaceous units located on the face, chest, and back. Skin is one of the most readily available organs on human body for topical management and is the major route of topical drug delivery system. Topical drug administration is a localized drug delivery system everywhere in the body during ophthalmic, vaginal, rectal and skin as topical routes. SA niosomes gel delivery system (SANG1 to SANG5) as a dispersed system, which consists of small droplets and well distributed in to immiscible vehicle. Niosome salicylic acid was prepared by Reverse phase evaporation method using cholesterol and span 80 and tween 20. Niosome were evaluated for vesicle shape, size determination, Entrapment efficiency and in-vitro drug release study. The result concluded that SANG5 was best formulation with Carbopol 940 (2g), PVP, nutmeg oil base. The drug release profile and release kinetics are two important characteristics of the dosage forms, which play an important role for describing dissolution profile of dosage form.
Keywords: Topical drug delivery, Acne vulgaris, Niosomes, Gel, Carbopol 940, nutmeg oil
Keywords:
Topical drug delivery, Acne vulgaris, Niosomes, Gel, Carbopol 940, nutmeg oilDOI
https://doi.org/10.22270/jddt.v13i10.5971References
Gupta MA, Gupta AK, Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis, Br J Dermatol, 1998; 139(5):846-850. https://doi.org/10.1046/j.1365-2133.1998.02511.x PMid:9892952
Cunliffe WJ, Natural history of acne. In: Cunliffe WJ, editor. Acne. London: Martin Dunitz, 1989; pp. 2-10.
Gollnick HP, Zouboulis CC, Akamatsu H, Kurokawa I, Schulte A, Pathogenesis and pathogenesis related treatment of acne, J Dermatol, 1991; 18(9):489-499. https://doi.org/10.1111/j.1346-8138.1991.tb03122.x PMid:1838558
Harris HH, Downing DT, Stewart ME, Strauss JS. Sustainable rates of sebum secretion in acne patients and matched normal control subjects, J Am Acad Dermatol, 1983; 8(2):200-203. https://doi.org/10.1016/S0190-9622(83)70023-X PMid:6219137
Blauer M, Vaalasti A, Pauli SL, Ylikomi T, Joensuu T, Tuohimaa P, Location of androgen receptor in human skin, J Invest Dermatol, 1991; 97(2):264-268. https://doi.org/10.1111/1523-1747.ep12480373 PMid:1830074
Choudhry R, Hodgins MB, Van der Kwast TH, Brinkmann AO, Boersma WJ, Localization of androgen receptors in human skin by immunohistochemistry: Implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands, J Endocrinol, 1992; 133(3):467-475. https://doi.org/10.1677/joe.0.1330467 PMid:1613448
Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW, Tissue distribution and ontogeny of steroid 5a-reductase isozyme expression, J Clin Invest, 1993; 92(2):903-910. https://doi.org/10.1172/JCI116665 PMid:7688765 PMCid:PMC294929
Luu-The V, Sugimoto Y, Puy L, Labrie Y, Lopez-Solache I, Singh M, Characterization, expression, and immunohistochemical localization of 5-a-reductase in human skin, J Invest Dermatol, 1994; 102(2):221-226. https://doi.org/10.1111/1523-1747.ep12371766 PMid:8106751
Thiboutot D, Harris G, Iles V, Cimis G, Gilliland K, Hagari S, Activity of the type I 5 a-reductase exhibits regional differences in isolated sebaceous glands and whole skin, J Invest Dermatol, 1995; 105 (2):209-214. https://doi.org/10.1111/1523-1747.ep12317162 PMid:7636302
Chen W, Zouboulis CC, Orfanos CE, The 5 areductase system and its inhibitors: Recent development and its perspective in treating androgen- dependent skin disorders, Dermatology, 1996; 193(3):177-184. https://doi.org/10.1159/000246242 PMid:8944337
Ourani-Pourdashti S, Mirzaei E, Heidari R, Ashrafi H, Azadi A, Preparation and evaluation of niosomal chitosan-based in situ gel formulation for direct nose-to-brain methotrexate delivery, Int J Biol Macromol. 2022; 213(1):1115-1126. https://doi.org/10.1016/j.ijbiomac.2022.06.031 PMid:35691430
Published
Abstract Display: 380 
PDF Downloads: 407 PDF Downloads: 73 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.